Medicinal cannabis is currently experiencing a resurgence as a highly beneficial and therapeutic plant following almost a century of prohibition and misinformation. Join with the medicinal cannabis community – doctors, researchers, allied health, clinicians, pharmacists, community advocates and industry for a full day meeting to discuss and debate this new frontier in human health.
Held as part of the 2020 Wellbeing Evidence and Horizons Conference, access the latest results from academic and research trials and hear the contemporary evidence to support medical cannabis as a valuable option for treating a range of symptoms.
“Cannabis as a medicine is nothing new; however prohibition and misinformation over the past century has set us back in terms of research, cultivation and acceptance of what is now re-emerging as a highly beneficial and therapeutic medicinal plant.”
Emily Rigby, Director of Research & Compliance for CANNATREK and Director of Research Programs for the AIMC – Australian Institute for Medical Cannabis
Key Reasons to Attend:
- Access the latest results and evidence from academic and research trails
- Understand medicinal cannabis as a treatment option for a variety of medical conditions
- Discover the research and growing evidence supporting medicinal cannabis
- Hear from leading Doctors prescribing cannabis medicines and how to navigate the TGA
- Case studies from Australian Doctors and specialists regarding dosage and titration methods
- Industry updates in this new and emerging field in Australia with a global perspective
- Education for health professionals including access
Director of Research & Compliance for CANNATREK
Director of Research Programs for the AIMC – Australian Institute for Medical Cannabis
Emily Rigby is a research scientist who is a passionate advocate for Medicinal Cannabis – promoting Australian patient access, education and regulatory reform. She is dedicated to removing the stigma surrounding the Cannabis plant and facilitating the emerging medicinal cannabis industry in Australia.
Research Fellow, NICM Health Research Institute, Western Sydney University, New South Wales
As one of Australia’s foremost experts in medicinal cannabis, Justin has spent the last decade investigating medicinal cannabis use both in Australia and the USA.
Discipline of Pharmacology
University of Adelaide
Scott holds a senior lectureship in The Discipline of Pharmacology at The University of Adelaide and has been actively investigating the effects and interaction of endogenous cannabinoid and prostanoid pathways in the expression of inflammatory bowel disease, particularly their influence on immune function in colitis. He has also developed collaborative projects investigating the influence of cannabinoid ligands on aspects of drug dependence and the role of cannabinoids and bioactives on neuroprotection.
Founder – MediHuanna
Dr Towpik has been a General Practitioner in Australia since 1993 and an advocate of medicinal cannabis since the law was amended and cannabis was legalised for medicinal use. Since then she has been studying the therapeutic properties of cannabis, how it works in the human body and the potential applications in General Practice, especially in the management of chronic debilitating pain.
In 2016, Dr Towpik founded MediHuanna, an organisation that provides science-based medicinal cannabis education for Health Professionals.
Dr John Teh is a practicing cannabis clinician and medical director for Plant Med cannabis clinics, based in Brisbane Australia. Dr Teh is an active medical educator in the cannabis medicine area for doctors, allied health and patients. Curator of the Australian Cannabis Summit (www.australiancannabissummit.com) Dr Teh is dedicated to further education in cannabis medicine for medical practitioners.
Dr Joe Kosterich
M.B.B.S (WA) 1985
Doctor, speaker, author, and health industry consultant, Dr Joe writes for medical and mainstream publications and is a regular on radio and television. He is often called to give opinions in medico legal cases, is clinical editor of Medical Forum Magazine and advisor to Reed Medical Conferences.
Medical Advisor to Medicinal Cannabis company Little Green Pharma, Dr Joe also sits on the board of Public Health Collaboration Australia and is Chairman of Australian Tobacco Harm Reduction Association
Previously he held senior positions in the Australian Medical Association and sat on numerous industry and government boards.
Through all this he continues to see patients as a GP each week.
Lucy is a retired nurse, mother and grandmother who with her son Dan began the campaign to reintroduce medicinal cannabis into Australia in 2014. Dan at that time was suffering from stage 4 bowel cancer and received incredible relief from cannabis but both he and his mother were criminals for procuring illicit cannabis to ease his suffering.
Dan lost his battle in February 2015. Despite this, Lucy’s campaign for the re-introduction of Medicinal Cannabis saw its legal status change on the first anniversary of his death. Lucy founded the charity United in Compassion in 2014 and she now sees her role as both advocate for other patients and as an educator in Dan’s memory. In her role as UIC Director Lucy strives to keep the emerging industry patient centric and morally grounded and still battles the politics to better patient access.
Health House International
Paul is a registered Australian and UK pharmacist. His company Health House was granted the first medicinal cannabis import license in Australia and he is currently distributing medicinal cannabis products to eligible patients. Over the last 30 years he has owned several retail pharmacies and worked both in Australia and the UK. In the last 3 years he has focussed on researching medicinal cannabis and has been to conferences, grow and manufacturing facilities and spoken to patients and prescribers in the US, Canada, Israel and South America. www.healthhouse.com.au
Professor Iain McGregor
Lambert Initiative for Cannabinoid Therapeutics
Brain and Mind Centre
University of Sydney
Iain McGregor is Professor of Psychopharmacology, NHMRC Principal Research Fellow and Academic Director of the Lambert Initiative for Cannabinoid Therapeutics in the Brain and Mind Centre at the University of Sydney, Australia.
Iain’s historical research has focused on the effects of drugs on the brain and behaviour and more recently on the discovery and development of new medications for the treatment of disease. His research spans medicinal chemistry, in silico pharmacology, the use of cellular assays and preclinical animal models of disease, and also clinical trials.
Iain has a strong interest in the area of medicinal cannabis with more than 20 years of experience in cannabinoid research. The Lambert Initiative for Cannabinoid Therapeutics was formed in 2015 with a gift of unprecedented generosity from the Lambert family to the University of Sydney.
The Lambert Initiative aims to fast track research into the therapeutic benefits of cannabinoids in various disease states including epilepsy, anxiety, pain, cancer and mental health conditions. The Lambert Initiative is also engaged at a social and political level to improve community and professional education around medicinal cannabis and to bring about evidence-based regulatory change and improved patient access.